序号	中文	英文	操作
121	Prakash Ghimire, Tribhuvan University, Nepal	Prakash Ghimire, Tribhuvan University, Nepal	查看中文全文00003 查看英文全文00003
122	Nikolaj Gilbert, Program for Appropriate Technology in Health (PATH), USA	Nikolaj Gilbert, Program for Appropriate Technology in Health (PATH), USA	查看中文全文00003 查看英文全文00003
123	Sarah Gilbert, University of Oxford, UK	Sarah Gilbert, University of Oxford, UK	查看中文全文00003 查看英文全文00003
124	Marion F. Gruber, Food and Drug Administration, U.S. Department of Health and Human Services, USA	Marion F. Gruber, Food and Drug Administration, U.S. Department of Health and Human Services, USA	查看中文全文00003 查看英文全文00003
125	Farshad Guirakhoo, GeoVax Inc, USA	Farshad Guirakhoo, GeoVax Inc, USA	查看中文全文00003 查看英文全文00003
126	Bart L Haagmans, Erasmus Medical Center, The Netherlands	Bart L Haagmans, Erasmus Medical Center, The Netherlands	查看中文全文00003 查看英文全文00003
127	M. Elizabeth Halloran, Center for Inference and Dynamics of Infectious Diseases, Fred Hutchinson Cancer Research Center, and University of Washington, USA	M. Elizabeth Halloran, Center for Inference and Dynamics of Infectious Diseases, Fred Hutchinson Cancer Research Center, and University of Washington, USA	查看中文全文00003 查看英文全文00003
128	Scott Harris, Altimmune Inc, USA	Scott Harris, Altimmune Inc, USA	查看中文全文00003 查看英文全文00003
129	Hideki Hasegawa, National Institute of Infectious Diseases, Japan	Hideki Hasegawa, National Institute of Infectious Diseases, Japan	查看中文全文00003 查看英文全文00003
130	Richard Hatchett, on behalf of the Coalition for Epidemic Preparedness Innovations (CEPI), Norway	Richard Hatchett, on behalf of the Coalition for Epidemic Preparedness Innovations (CEPI), Norway	查看中文全文00003 查看英文全文00003